Atlas Trials

Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients

Clinical trial NCT03079947 · UNKNOWN

Trial details

NCT number
NCT03079947
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Diffuse Large B Cell LymphomaPeripheral T Cell Lymphoma
Start date
2017-01-01
Primary completion
2020-01-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.